Evolving Options for the Treatment of HCC With Immunotherapy and Liver Directed Therapy (LDT)
Released On
July 31, 2023
Expires On
July 30, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Hematology-Oncology, Hepatology, Hospitalist, Pathology, Radiology
Topic(s)
Hepatocellular Carcinoma
This activity is provided by The France Foundation
This activity is supported by an educational grant from AstraZeneca.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of interventional radiologists/oncologists, physicians, nurses, and other members of the health care team who care for patients with HCC.
Program Overview
This activity will cover ongoing research on emerging immunotherapy agents and clinical trial data on the use of the agents in combination, succession, and sequentially with interventional liver directed therapy (LDT).
Learning Objectives
Upon completion of this activity, participants should be able to:
- Differentiate the clinical profiles of current and emerging immunotherapy agents for the management of HCC
- Analyze clinical trial data related to the use of immunotherapy agents in combination and suceession with interventional techniques for HCC
- Advise clinical colleagues on immunotherapy treatment as part of the multidisciplinary HCC cancer treatment team
Faculty
Ben George, MD
William F. Stapp Endowed Chair
Associate Professor of Medicine
Associate Director for Cancer Genomics and Precision Medicine
Medical College of Wisconsin
Milwaukee, WI
Amanda Smolock, MD
Assistant Professor
Department of Radiology
Medical College of Wisconsin
Milwaukee, WI
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by The France Foundation and Society for Interventional Oncology (SIO). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
PAs may claim a maximum of xx Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
All other healthcare professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts of Interest
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers (Desktop/Mobile)
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
TFF and SIO require that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected].